User profiles for Richard Haynes

Richard Haynes

Professor, Senior Principal Research Fellow (Rural and Global Health) Rural Health …
Verified email at csu.edu.au
Cited by 9770

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

…, R Bulbulia, K Rahimi, R Haynes… - Lancet (London …, 2010 - ora.ox.ac.uk
Background Lowering of LDL cholesterol reduces major vascular events, but whether more
intensive therapy safely produces extra benefi ts is uncertain. We aimed to establish effi cacy …

Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report

…, K Rowan, E Juszczak, JK Baillie, R Haynes… - MedRxiv, 2020 - medrxiv.org
Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …

Influence of lime, fertilizer and manure applications on soil organic matter content and soil physical conditions: a review

RJ Haynes, R Naidu - Nutrient cycling in agroecosystems, 1998 - Springer
The effects of lime, fertilizer and manure applications on soil organic matter status and soil
physical properties are of importance to agricultural sustainability. Their effects are complex …

[HTML][HTML] Artemisinins: their growing importance in medicine

S Krishna, L Bustamante, RK Haynes… - Trends in pharmacological …, 2008 - cell.com
Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well
established for the treatment of malaria, including highly drug-resistant strains. Their efficacy …

Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis

…, AC Gordon, A Granholm, C Green, R Haynes… - Jama, 2020 - jamanetwork.com
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …

[HTML][HTML] Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, A Montgomery, K Rowan, E Juszczak, R Haynes… - The Lancet, 2020 - thelancet.com
Background Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis
of in vitro activity, preclinical studies, and observational studies. Here, we report the results …

[HTML][HTML] Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled …

C Baigent, JR Emberson, R Haynes, WG Herrington… - The Lancet, 2022 - thelancet.com
Background Large trials have shown that sodium glucose co-transporter-2 (SGLT2) inhibitors
reduce the risk of adverse kidney and cardiovascular outcomes in patients with heart …

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

…, K Rowan, G Thwaites, M Mafham, R Haynes… - Medrxiv, 2021 - medrxiv.org
Background Tocilizumab is a monoclonal antibody that binds to the receptor for interleukin (IL)-6,
reducing inflammation, and is commonly used to treat rheumatoid arthritis. We …

The 1980 softwood timber assessment market model: structure, projections, and policy simulations

DM Adams, RW Haynes - Forest Science, 1980 - academic.oup.com
The paper presents a spatial model of North American softwood lumber, plywood, and
stumpage markets designed to provide long-range projections of price, consumption, and …

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, K Rowan, G Thwaites, DM Weinreich, R Haynes… - Medrxiv, 2021 - medrxiv.org
Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV-2 …